Wall Street’s UnitedHealth stock forecast factors in upcoming FDA and policy developments, with defensive healthcare positioning boosting relative strength compared to S&P 500 benchmarks. We'll now explore how these Medicare Advantage changes and regulatory challenges could reshape UnitedHealth Group's investment narrative. According to TipRanks A.I. Stock Analysis , UNH earns a solid score of 72 out of 100 with an Outperform rating. Meanwhile, the A.I. analyst assigns UnitedHealth a price target of $386, implying a 7.2% upside potential. Technical momentum in the UnitedHealth stock forecast is supported by MACD crossovers in bullish territory, suggesting upward bias heading into July trading sessions.